The centre for Applied Ethics was created in April 2014 as part of a broad restructuring of ethics services at the MUHC. The 9 Research Ethics Boards (REBs), as well as research ethics, support services have been part of this exercise. Changes to the REB structure come into effect April 1, 2015. These will not affect the general principles of how research involving humans is approved. However, these changes aim at increasing efficiency while maintaining high-quality review of research.
- There is one MUHC REB and 5 specialised panels
- The 5 specialised panels will conduct both Science and Ethics review and will meet twice a month on average;
- Submission deadlines are abolished;
- The CAE staff will conduct pre-reviews of all studies to ensure
- completeness,
- minimal quality of documents submitted and
- assess level of risk and initiate delegated review of minimal risk studies (instead of full board reviews).
The MUHC currently has a single REB with 5 specialized panels :
- PED
- NEUPSY
- CT1 (Oncology)
- CT2
- CTGQ
5 Panels of the MUHC-REB
Pediatrics (PED):
|
Neurosciences-Psychiatry (NEUPSY): All projects in:
|
MUHC REB Chair: Marie Hirtle Person formally mandated at the MUHC to authorize projects: Annie Duguay |
||
Panels |
Co-Chairs: |
REB Coordination |
PEDS |
Dr. Carlo Cicero |
Ms. Elizabeth Craven |
NEUPSY |
Dr. Serge Gauthier, Mr. Renaud Boulanger |
Ms. Joanne Lebrasseur |
CT1 |
Mr. Vincent Lajoie |
Ms. Elizabeth Craven |
CT2 |
Dr. Bertrand Lebouché, Ms. Sonya Page, Ms. Franca Cantini, Me Brigitte Paquet |
Ms. Sonia Cantini |
CTGQ |
Me Marie Hirtle | Mr. James Ellasus |
Schedule of REB FULLBOARD meetings
For the schedule of REB full board meetings, please see calendar page on Nagano. Note that studies that are more than minimal risk are reviewed at the fullboard.
Please enter your study in Nagano as soon as possible to initiate the review process.
Updated June 16 2023